ChREBP binding and histone modifications modulate hepatic expression of the Fasn gene in a metabolic syndrome rat model

Nutrition

Volumn 31, Issue 6, 2015, Pages 877-883

  Suzuki, Takuji ^a,b   Muramatsu, Takeshi ^a   Morioka, Kousuke ^a   Goda, Toshinao ^a   Mochizuki, Kazuki ^a,c  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

ChREBP; Histone modifications; Insulin resistance; Lipogenesis; Liver

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; FATTY ACID SYNTHASE; HISTONE H3; RNA POLYMERASE II; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; HISTONE; INSULIN; LYSINE; MESSENGER RNA; WBSCR14 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENHANCER REGION; EPIGENETICS; FASN GENE; GENE EXPRESSION; HISTONE MODIFICATION; IMMUNOBLOTTING; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ACETYLATION; ANIMAL; GENETIC EPIGENESIS; GENETICS; HISTONE CODE; LIPOGENESIS; LIVER; METABOLISM; METHYLATION; PROTEIN PROCESSING; SPONTANEOUSLY HYPERTENSIVE RAT;

RATTUS;

ACETYLATION; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; EPIGENESIS, GENETIC; FATTY ACID SYNTHASES; HISTONE CODE; HISTONES; INSULIN; INSULIN RESISTANCE; LIPOGENESIS; LIVER; LYSINE; MALE; METABOLIC SYNDROME X; METHYLATION; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, INBRED SHR; RNA, MESSENGER;

EID: 84928529043     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.01.005     Document Type: Article

References (51)

1. Gorter P.M., Olijhoek J.K., van der Graaf Y., Algra A., Rabelink T.J., Visseren F.L. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 2004, 173:363-369.
2. Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56:1113-1132.
3. Katsurada A., Iritani N., Fukuda H., Matsumura Y., Nishimoto N., Noguchi T., et al. Effects of nutrients and hormones on transcriptional and posttranscriptional regulation of fatty acid synthase in rat liver. Eur J Biochem 1990, 190:427-433.
4. Katsurada A., Iritani N., Fukuda H., Matsumura Y., Nishimoto N., Noguchi T., et al. Effects of nutrients and hormones on transcriptional and posttranscriptional regulation of acetyl-CoA carboxylase in rat liver. Eur J Biochem 1990, 190:435-441.
5. Triscari J., Greenwood M.R., Sullivan A.C. Regulation of lipid synthesis in hepatocytes from lean and obese Zucker rats. Metabolism 1981, 30:1135-1142.
6. Memon R.A., Grunfeld C., Moser A.H., Feingold K.R. Fatty acid synthesis in obese insulin resistant diabetic mice. Horm Metab Res 1994, 26:85-87.
7. Shimomura I., Bashmakov Y., Horton J.D. Increased levels of nuclear SREBP-1 c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999, 274:30028-30032.
8. Kawaguchi T., Takenoshita M., Kabashima T., Uyeda K. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A 2001, 98:13710-13715.
9. Rufo C., Teran-Garcia M., Nakamura M.T., Koo S.H., Towle H.C., Clarke S.D. Involvement of a unique carbohydrate-responsive factor in the glucose regulation of rat liver fatty-acid synthase gene transcription. J Biol Chem 2001, 276:21969-21975.
10. Yamashita H., Takenoshita M., Sakurai M., Bruick R.K., Henzel W.J., Shillinglaw W., et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 2001, 98:9116-9121.
11. Wang H., Cao R., Xia L., Erdjument-Bromage H., Borchers C., Tempst P., et al. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 2001, 8:1207-1217.
12. Musri M.M., Corominola H., Casamitjana R., Gomis R., Parrizas M. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem 2006, 281:17180-17188.
13. Suzuki T., Douard V., Mochizuki K., Goda T., Ferraris R.P. Diet-induced epigenetic regulation invivo of the intestinal fructose transporter Glut5 during development of rat small intestine. Biochem J 2011, 435:43-53.
14. Inoue S., Mochizuki K., Goda T. Jejunal induction of SI and SGLT1 genes in rats by high-starch/low-fat diet is associated with histone acetylation and binding of GCN5 on the genes. J Nutr Sci Vitaminol (Tokyo) 2011, 57:162-169.
15. Miao F., Wu X., Zhang L., Yuan Y.C., Riggs A.D., Natarajan R. Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem 2007, 282:13854-13863.
16. Shimada M., Mochizuki K., Goda T. Methylation of histone H3 at lysine 4 and expression of the maltase-glucoamylase gene are reduced by dietary resistant starch. J Nutr Biochem 2013, 24:606-612.
17. Yoshinaga Y., Mochizuki K., Goda T. Trimethylation of histone H3 K4 is associated with the induction of fructose-inducible genes in rat jejunum. Biochem Biophys Res Commun 2012, 419:605-611.
18. Nangaku M., Miyata T., Sada T., Mizuno M., Inagi R., Ueda Y., et al. Antihypertensive agents inhibit invivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. J Am Soc Nephrol 2003, 14:1212-1222.
19. Hariya N., Mochizuki K., Inoue S., Morioka K., Shimada M., Okuda T., et al. Insulin resistance in SHR/NDmc-cp rats correlates with enlarged perivascular adipcytes and endothelial cell dysfunction in skeletal muscle. J Nutr Sci Vitaminol (Tokyo) 2014, 60:52-59.
20. Chomczynski P., Sacchi N. The single-step method of RNA isolation by acidguanidinium thiocyanate-phenol-chloroform extraction: Twenty-something years on. Nat Protoc 2006, 1:581-585.
21. Suzuki T., Mochizuki K., Goda T. Localized expression of genes related to carbohydrate and lipid absorption along the crypt-villus axis of rat jejunum. Biochim Biophys Acta 2009, 1790:1624-1635.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
23. Hariya N., Miyake K., Kubota T., Goda T., Mochizuki K. Putative PPAR target genes express highly in skeletal muscle of insulin-resistant MetS model SHR/NDmc-cp rats. J Nutr Sci Vitaminol (Tokyo) 2015, 61:28-36.
24. Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Morales P.A., Stern M.P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992, 41:715-722.
25. Harikai N., Hashimoto A., Semma M., Ichikawa A. Characteristics of lipolysis in white adipose tissues of SHR/NDmc-cp rats, a model of metabolic syndrome. Metabolism 2007, 56:847-855.
26. Dentin R., Benhamed F., Hainault I., Fauveau V., Foufelle F., Dyck J.R., et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006, 55:2159-2170.
27. Davy K.P., Orr J.S. Sympathetic nervous system behavior in human obesity. Neurosci Biobehav Rev 2009, 33:116-124.
28. Correia M.L., Morgan D.A., Sivitz W.I., Mark A.L., Haynes W.G. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension 2001, 37:936-942.
29. Rahmouni K., Haynes W.G., Morgan D.A., Mark A.L. Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 2003, 41:763-767.
30. Bolli G., De Feo P., Massi-Benedetti M., Compagnucci P., Cartechini M.G., Santeusanio F., et al. Circulating catecholamine and glucagon responses to insulin-induced blood glucose decrement in a patient with pheochromocytoma. J Clin Endocrinol Metab 1982, 54:447-449.
31. Campese V.M. The kidney and the neurogenic control of blood pressure in renal disease. J Nephrol 2000, 13:221-224.
32. Warne J.P., Alemi F., Reed A.S., Varonin J.M., Chan H., Piper M.L., et al. Impairment of central leptin-mediated PI3 K signaling manifested as hepatic steatosis independent of hyperphagia and obesity. Cell Metab 2011, 14:791-803.
33. Hiraoka J., Hosoda K., Ogawa Y., Ikeda K., Nara Y., Masuzaki H., et al. Augmentation of obese (ob) gene expression and leptin secretion in obese spontaneously hypertensive rats (obese SHR or Koletsky rats). Biochem Biophys Res Commun 1997, 231:582-585.
34. Ishizuka T., Ernsberger P., Liu S., Bedol D., Lehman T.M., Koletsky R.J., et al. Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB). J Nutr 1998, 128:2299-2306.
35. Velasque M.T., Bhathena S.J., Hansen C.T. Leptin and its relation to obesity and insulin in the SHR/N-corpulent rat, a model of type II diabetes mellitus. Int J Exp Diabetes Res 2001, 2:217-223.
36. Kim T.S., Freake H.C. High carbohydrate diet and starvation regulate lipogenic mRNA in rats in a tissue-specific manner. J Nutr 1996, 126:611-617.
37. Brass E.P., Vetter W.H. Interleukin-6, but not tumour necrosis factor-alpha, increases lipogenesis in rat hepatocyte primary cultures. Biochem J 1994, 301:193-197.
38. Nachiappan V., Curtiss D., Corkey B.E., Kilpatrick L. Cytokines inhibit fatty acid oxidation in isolated rat hepatocytes: synergy among TNF, IL-6, and IL-1. Shock 1994, 1:123-129.
39. Han C., Wang J., Li L., Zhang Z., Wang L., Pan Z. The role of insulin and glucose in goose primary hepatocyte triglyceride accumulation. J Exp Biol 2009, 212:1553-1558.
40. Matsuzaka T., Shimano H., Yahagi N., Amemiya-Kudo M., Okazaki H., Tamura Y., et al. Insulin-independent induction of sterol regulatory element-binding protein-1 c expression in the livers of streptozotocin-treated mice. Diabetes 2004, 53:560-569.
41. Shih H.M., Liu Z., Towle H.C. Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J Biol Chem 1995, 270:21991-21997.
42. da Silva Xavier G., Rutter G.A., Diraison F., Andreolas C., Leclerc I. ChREBP binding to fatty acid synthase and L-type pyruvate kinase genes is stimulated by glucose in pancreatic beta-cells. J Lipid Res 2006, 47:2482-2491.
43. Iizuka K., Takeda J., Horikawa Y. Glucose induces FGF21 mRNA expressionthrough ChREBP activation in rat hepatocytes. FEBS Lett 2009, 583:2882-2886.
44. Honma K., Mochizuki K., Goda T. Carbohydrate/fat ratio in the dietalters histone acetylation on the sucrase-isomaltase gene and its expression in mouse small intestine. Biochem Biophys Res Commun 2007, 357:1124-1129.
45. Schneider R., Bannister A.J., Myers F.A., Thorne A.W., Crane-Robinson C., Kouzarides T. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 2004, 6:73-77.
46. Soutoglou E., Talianidis I. Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation. Science 2002, 295:1901-1904.
47. Jang M.K., Mochizuki K., Zhou M., Jeong H.S., Brady J.N., Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 2005, 19:523-534.
48. Nightingale K.P., Gendreizig S., White D.A., Bradbury C., Hollfelder F., Turner B.M. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3 K4 methylation. J Biol Chem 2007, 282:4408-4416.
49. El-Osta A., Brasacchio D., Yao D., Pocai A., Jones P.L., Roeder R.G., et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008, 205:2409-2417.
50. Chen W.L., Wei H.W., Chiu W.Z., Kang C.H., Lin T.H., Hung C.C., et al. Metformin regulates hepatic lipid metabolism through activating AMP-activated protein kinase and inducing ATGL in laying hens. Eur J Pharmacol 2011, 671:107-112.
51. Lee Y.S., Shin S., Shigihara T., Hahm E., Liu M.J., Han J., et al. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis. Diabetes 2007, 56:1671-1679.